

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.91961014 |
| 2 | vocalization behavior (GO:0071625) | 5.53295395 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.38250531 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.35560327 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.16203637 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.06957312 |
| 7 | protein localization to synapse (GO:0035418) | 5.06853358 |
| 8 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.93589777 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.92661550 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.87674740 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.79911356 |
| 12 | glutamate secretion (GO:0014047) | 4.72639429 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.72459637 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.69465163 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.67714356 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67613582 |
| 17 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.67375727 |
| 18 | * glutamate receptor signaling pathway (GO:0007215) | 4.57009630 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.50754151 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.44851487 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.42285503 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.36009085 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.33986614 |
| 24 | presynaptic membrane assembly (GO:0097105) | 4.32307274 |
| 25 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.15807908 |
| 26 | exploration behavior (GO:0035640) | 4.14524581 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.13725844 |
| 28 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.06934234 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.04960758 |
| 30 | presynaptic membrane organization (GO:0097090) | 4.02991413 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.02714204 |
| 32 | C4-dicarboxylate transport (GO:0015740) | 4.01912003 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.00731528 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.98107679 |
| 35 | neuron recognition (GO:0008038) | 3.93944547 |
| 36 | nucleobase catabolic process (GO:0046113) | 3.86490046 |
| 37 | positive regulation of synapse maturation (GO:0090129) | 3.84860456 |
| 38 | postsynaptic membrane organization (GO:0001941) | 3.84447529 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.83763729 |
| 40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.72795897 |
| 41 | long-term memory (GO:0007616) | 3.72328364 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.71323730 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.70712923 |
| 44 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.69238289 |
| 45 | response to histamine (GO:0034776) | 3.68721262 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68209648 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.63632216 |
| 48 | dendritic spine morphogenesis (GO:0060997) | 3.62934159 |
| 49 | epithelial cilium movement (GO:0003351) | 3.61647495 |
| 50 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.61163207 |
| 51 | retinal cone cell development (GO:0046549) | 3.60363202 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 3.57826579 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.56320474 |
| 54 | regulation of cilium movement (GO:0003352) | 3.55981524 |
| 55 | * G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.54909734 |
| 56 | axonal fasciculation (GO:0007413) | 3.53239495 |
| 57 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.51373579 |
| 58 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.46541090 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.46504042 |
| 60 | long-term synaptic potentiation (GO:0060291) | 3.45397606 |
| 61 | * transmission of nerve impulse (GO:0019226) | 3.43608984 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.39938823 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.39426808 |
| 64 | response to pheromone (GO:0019236) | 3.39162918 |
| 65 | neurotransmitter transport (GO:0006836) | 3.38428230 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.37970598 |
| 67 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.37320972 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 3.35916162 |
| 69 | membrane depolarization (GO:0051899) | 3.35313027 |
| 70 | membrane depolarization during action potential (GO:0086010) | 3.35225999 |
| 71 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.33686579 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.31146352 |
| 73 | regulation of neurotransmitter secretion (GO:0046928) | 3.31096045 |
| 74 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.30155346 |
| 75 | startle response (GO:0001964) | 3.28796880 |
| 76 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.28220253 |
| 77 | detection of light stimulus involved in visual perception (GO:0050908) | 3.28220253 |
| 78 | * behavioral defense response (GO:0002209) | 3.25087632 |
| 79 | * behavioral fear response (GO:0001662) | 3.25087632 |
| 80 | nonmotile primary cilium assembly (GO:0035058) | 3.25037821 |
| 81 | protein localization to cilium (GO:0061512) | 3.24820864 |
| 82 | proline transport (GO:0015824) | 3.24737563 |
| 83 | regulation of action potential (GO:0098900) | 3.24462497 |
| 84 | regulation of dendritic spine development (GO:0060998) | 3.21460236 |
| 85 | neuronal action potential (GO:0019228) | 3.21061818 |
| 86 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.20949069 |
| 87 | cilium movement (GO:0003341) | 3.20787227 |
| 88 | axoneme assembly (GO:0035082) | 3.18211666 |
| 89 | positive regulation of synapse assembly (GO:0051965) | 3.16275180 |
| 90 | fucose catabolic process (GO:0019317) | 3.16223773 |
| 91 | L-fucose metabolic process (GO:0042354) | 3.16223773 |
| 92 | L-fucose catabolic process (GO:0042355) | 3.16223773 |
| 93 | auditory behavior (GO:0031223) | 3.13591911 |
| 94 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13475227 |
| 95 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.12680158 |
| 96 | regulation of synapse maturation (GO:0090128) | 3.12248204 |
| 97 | synapse assembly (GO:0007416) | 3.12087425 |
| 98 | activation of protein kinase A activity (GO:0034199) | 3.10884123 |
| 99 | * learning (GO:0007612) | 3.10487147 |
| 100 | regulation of neurotransmitter levels (GO:0001505) | 3.10141428 |
| 101 | membrane hyperpolarization (GO:0060081) | 3.08211533 |
| 102 | * fear response (GO:0042596) | 3.08040355 |
| 103 | dendrite morphogenesis (GO:0048813) | 3.07745532 |
| 104 | neuronal ion channel clustering (GO:0045161) | 3.06560282 |
| 105 | * synaptic transmission (GO:0007268) | 3.05146896 |
| 106 | neuromuscular process controlling balance (GO:0050885) | 3.04518381 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 3.04226583 |
| 108 | positive regulation of dendritic spine development (GO:0060999) | 3.02392968 |
| 109 | response to auditory stimulus (GO:0010996) | 3.02320913 |
| 110 | synaptic vesicle endocytosis (GO:0048488) | 3.01936779 |
| 111 | * regulation of synaptic transmission (GO:0050804) | 3.01175403 |
| 112 | regulation of female receptivity (GO:0045924) | 2.99658298 |
| 113 | adult walking behavior (GO:0007628) | 2.99621706 |
| 114 | neuromuscular process controlling posture (GO:0050884) | 2.97622268 |
| 115 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97593128 |
| 116 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97358822 |
| 117 | positive regulation of synaptic transmission (GO:0050806) | 2.96929813 |
| 118 | behavioral response to cocaine (GO:0048148) | 2.96892408 |
| 119 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.94419344 |
| 120 | dendritic spine organization (GO:0097061) | 2.93125815 |
| 121 | protein polyglutamylation (GO:0018095) | 2.91947548 |
| 122 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.89962360 |
| 123 | mechanosensory behavior (GO:0007638) | 2.88224759 |
| 124 | innervation (GO:0060384) | 2.86954156 |
| 125 | regulation of protein kinase A signaling (GO:0010738) | 2.86218268 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.85876912 |
| 127 | negative regulation of dendrite development (GO:2000171) | 2.85511722 |
| 128 | glycosphingolipid biosynthetic process (GO:0006688) | 2.83717935 |
| 129 | behavioral response to ethanol (GO:0048149) | 2.83558227 |
| 130 | neural tube formation (GO:0001841) | 2.83544478 |
| 131 | neurofilament cytoskeleton organization (GO:0060052) | 2.80115155 |
| 132 | cilium morphogenesis (GO:0060271) | 2.77750978 |
| 133 | * short-term memory (GO:0007614) | 2.73467571 |
| 134 | axonemal dynein complex assembly (GO:0070286) | 2.73078280 |
| 135 | regulation of collateral sprouting (GO:0048670) | 2.72285299 |
| 136 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.68170766 |
| 137 | platelet dense granule organization (GO:0060155) | 2.67132865 |
| 138 | inner ear receptor stereocilium organization (GO:0060122) | 2.63132887 |
| 139 | regulation of microtubule-based movement (GO:0060632) | 2.61925540 |
| 140 | serotonin metabolic process (GO:0042428) | 2.61602694 |
| 141 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.60345744 |
| 142 | cAMP catabolic process (GO:0006198) | 2.59376478 |
| 143 | regulation of feeding behavior (GO:0060259) | 2.58640174 |
| 144 | central nervous system neuron axonogenesis (GO:0021955) | 2.56871439 |
| 145 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.56519583 |
| 146 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.56243289 |
| 147 | cilium organization (GO:0044782) | 2.53481373 |
| 148 | synaptic transmission, cholinergic (GO:0007271) | 2.52828647 |
| 149 | positive regulation of amino acid transport (GO:0051957) | 2.52395293 |
| 150 | cilium assembly (GO:0042384) | 2.51709676 |
| 151 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.51317802 |
| 152 | primary amino compound metabolic process (GO:1901160) | 2.50748622 |
| 153 | retinal ganglion cell axon guidance (GO:0031290) | 2.49792979 |
| 154 | negative regulation of response to food (GO:0032096) | 2.48070703 |
| 155 | negative regulation of appetite (GO:0032099) | 2.48070703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.19246341 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.17276124 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15845198 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09949950 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08608729 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64583801 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62729501 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62729501 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60998709 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.58776999 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54281562 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53060250 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49409564 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44678459 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39974245 |
| 16 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39473541 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38878118 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31474678 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26246506 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16145577 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15625188 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10899213 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.08755746 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07308854 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03264988 |
| 26 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96488239 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.95503776 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95229703 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89149672 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87683520 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.87226573 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86470999 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84640814 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.78845156 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77496017 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77262113 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74003890 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71492470 |
| 39 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.70129519 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64861929 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61878739 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59881327 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59367970 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58902586 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.54406538 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53782474 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52425919 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52425919 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50185071 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45209344 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45203588 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44753828 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40427289 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38671355 |
| 55 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35660288 |
| 56 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35633140 |
| 57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35431278 |
| 58 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35043119 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34957830 |
| 60 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34595146 |
| 61 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33892915 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31905764 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31429681 |
| 64 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30605677 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29949477 |
| 66 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29817352 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29374370 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28845469 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27921185 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27587066 |
| 71 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26948055 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.26462752 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26143499 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25712690 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23791029 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22878800 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22648397 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22125642 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21543045 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.20925107 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19911477 |
| 82 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18960345 |
| 83 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17015268 |
| 84 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15852951 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15149539 |
| 86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14136798 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13930537 |
| 88 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13577040 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13018886 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13018886 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12552959 |
| 92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12541053 |
| 93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12156122 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12046210 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11708391 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11108527 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10846416 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09101675 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08253735 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07992245 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07929392 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07497017 |
| 103 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07349143 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07263153 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06084495 |
| 106 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05945105 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05648396 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05348431 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05348431 |
| 110 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05078218 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04603614 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04430166 |
| 113 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.03601272 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 1.03197690 |
| 115 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01000123 |
| 116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00317613 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00225155 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99975802 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99868087 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99238554 |
| 121 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99072269 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99047514 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98869923 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96684172 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96425012 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95466360 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95319782 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95179750 |
| 129 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90564034 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90409747 |
| 131 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.88394230 |
| 132 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88064504 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87178926 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86655433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.96489766 |
| 2 | MP0003880_abnormal_central_pattern | 5.56608909 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.03636030 |
| 4 | MP0004270_analgesia | 3.63083827 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.58263117 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.53369756 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.24171222 |
| 8 | * MP0002064_seizures | 3.13601538 |
| 9 | MP0009046_muscle_twitch | 2.97875600 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.97439179 |
| 11 | MP0002736_abnormal_nociception_after | 2.90324081 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.86068662 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.77933734 |
| 14 | MP0002272_abnormal_nervous_system | 2.76068106 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.72626734 |
| 16 | MP0002822_catalepsy | 2.63357479 |
| 17 | MP0001486_abnormal_startle_reflex | 2.49503475 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.38051892 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.37290665 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.35760399 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.17984469 |
| 22 | MP0001970_abnormal_pain_threshold | 2.13913246 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.12750813 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.09920529 |
| 25 | MP0002102_abnormal_ear_morphology | 2.00303131 |
| 26 | MP0000778_abnormal_nervous_system | 1.91420781 |
| 27 | MP0002184_abnormal_innervation | 1.85506602 |
| 28 | MP0003329_amyloid_beta_deposits | 1.83441729 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.77791475 |
| 30 | MP0001529_abnormal_vocalization | 1.71500955 |
| 31 | MP0003879_abnormal_hair_cell | 1.70087546 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.68835446 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.68745486 |
| 34 | MP0004924_abnormal_behavior | 1.68745486 |
| 35 | MP0008569_lethality_at_weaning | 1.62577705 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.59485713 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.56331346 |
| 38 | MP0004142_abnormal_muscle_tone | 1.53672890 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.53106027 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.52967917 |
| 41 | MP0003195_calcinosis | 1.51928954 |
| 42 | MP0004858_abnormal_nervous_system | 1.49942016 |
| 43 | MP0003787_abnormal_imprinting | 1.48016902 |
| 44 | MP0000955_abnormal_spinal_cord | 1.47361350 |
| 45 | MP0004043_abnormal_pH_regulation | 1.45474615 |
| 46 | MP0001984_abnormal_olfaction | 1.44935219 |
| 47 | MP0005253_abnormal_eye_physiology | 1.43607726 |
| 48 | MP0001905_abnormal_dopamine_level | 1.42256784 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.42219918 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.41200634 |
| 51 | * MP0002066_abnormal_motor_capabilities/c | 1.38503563 |
| 52 | MP0001188_hyperpigmentation | 1.37001919 |
| 53 | MP0004885_abnormal_endolymph | 1.35255355 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.34534126 |
| 55 | MP0003121_genomic_imprinting | 1.32522613 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.32368811 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.26870523 |
| 58 | MP0003122_maternal_imprinting | 1.26378702 |
| 59 | MP0003633_abnormal_nervous_system | 1.24897602 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.23190223 |
| 61 | MP0003136_yellow_coat_color | 1.16639468 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15193685 |
| 63 | MP0003631_nervous_system_phenotype | 1.10685760 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.10683244 |
| 65 | MP0004742_abnormal_vestibular_system | 1.09367189 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.08137820 |
| 67 | MP0005171_absent_coat_pigmentation | 1.05913875 |
| 68 | MP0005410_abnormal_fertilization | 1.04214080 |
| 69 | MP0002229_neurodegeneration | 1.03507937 |
| 70 | MP0002152_abnormal_brain_morphology | 1.03283022 |
| 71 | MP0002876_abnormal_thyroid_physiology | 1.02166532 |
| 72 | MP0004147_increased_porphyrin_level | 1.00550259 |
| 73 | MP0003011_delayed_dark_adaptation | 1.00175231 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.99899151 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.99598642 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 0.96866824 |
| 77 | MP0000751_myopathy | 0.95818999 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.95584956 |
| 79 | MP0000920_abnormal_myelination | 0.95557195 |
| 80 | MP0005187_abnormal_penis_morphology | 0.95303258 |
| 81 | MP0008995_early_reproductive_senescence | 0.92416846 |
| 82 | MP0004133_heterotaxia | 0.92375665 |
| 83 | MP0001963_abnormal_hearing_physiology | 0.91335507 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.91117212 |
| 85 | MP0008874_decreased_physiological_sensi | 0.89858999 |
| 86 | MP0002160_abnormal_reproductive_system | 0.88710684 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.88632543 |
| 88 | MP0008872_abnormal_physiological_respon | 0.88121274 |
| 89 | MP0004085_abnormal_heartbeat | 0.86498002 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.86427815 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.84638524 |
| 92 | MP0003632_abnormal_nervous_system | 0.83534493 |
| 93 | MP0003698_abnormal_male_reproductive | 0.83526119 |
| 94 | MP0000427_abnormal_hair_cycle | 0.83480920 |
| 95 | MP0005195_abnormal_posterior_eye | 0.82845068 |
| 96 | MP0003634_abnormal_glial_cell | 0.82259983 |
| 97 | MP0005409_darkened_coat_color | 0.80740591 |
| 98 | MP0003690_abnormal_glial_cell | 0.80305044 |
| 99 | MP0000604_amyloidosis | 0.80105583 |
| 100 | MP0005535_abnormal_body_temperature | 0.78111504 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.76480494 |
| 102 | MP0001177_atelectasis | 0.76153225 |
| 103 | MP0002233_abnormal_nose_morphology | 0.75238979 |
| 104 | MP0002928_abnormal_bile_duct | 0.73186028 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.69387392 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68826644 |
| 107 | MP0003718_maternal_effect | 0.68383633 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.68179746 |
| 109 | MP0004484_altered_response_of | 0.66642866 |
| 110 | MP0000026_abnormal_inner_ear | 0.61346242 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.60450164 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.59899930 |
| 113 | MP0002090_abnormal_vision | 0.59735309 |
| 114 | MP0001664_abnormal_digestion | 0.59684667 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.57268994 |
| 116 | MP0005499_abnormal_olfactory_system | 0.57268994 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.56165815 |
| 118 | MP0001943_abnormal_respiration | 0.55964180 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.55589132 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.55460303 |
| 121 | MP0003075_altered_response_to | 0.53412291 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.52612661 |
| 123 | MP0002751_abnormal_autonomic_nervous | 0.49919585 |
| 124 | MP0003861_abnormal_nervous_system | 0.49655565 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.49419528 |
| 126 | MP0010770_preweaning_lethality | 0.49370161 |
| 127 | MP0002082_postnatal_lethality | 0.49370161 |
| 128 | MP0010769_abnormal_survival | 0.48962034 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.47627491 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.47065267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.54810013 |
| 2 | Myokymia (HP:0002411) | 6.23089129 |
| 3 | Focal seizures (HP:0007359) | 6.16018578 |
| 4 | Atonic seizures (HP:0010819) | 5.69372426 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.30063944 |
| 6 | Febrile seizures (HP:0002373) | 4.91573390 |
| 7 | Absence seizures (HP:0002121) | 4.62236142 |
| 8 | Visual hallucinations (HP:0002367) | 4.50488193 |
| 9 | Dialeptic seizures (HP:0011146) | 4.49858020 |
| 10 | Hyperventilation (HP:0002883) | 4.28806618 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 4.25124420 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.09140545 |
| 13 | Broad-based gait (HP:0002136) | 3.94697479 |
| 14 | Pancreatic cysts (HP:0001737) | 3.72942738 |
| 15 | Medial flaring of the eyebrow (HP:0010747) | 3.59352846 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.44268304 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.40145690 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.40145690 |
| 19 | True hermaphroditism (HP:0010459) | 3.31326865 |
| 20 | Action tremor (HP:0002345) | 3.30913281 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.26173094 |
| 22 | Amblyopia (HP:0000646) | 3.24514044 |
| 23 | Pancreatic fibrosis (HP:0100732) | 3.24334213 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.23959164 |
| 25 | Poor eye contact (HP:0000817) | 3.21779071 |
| 26 | Dysmetria (HP:0001310) | 3.17556198 |
| 27 | Truncal ataxia (HP:0002078) | 3.11520890 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.03820718 |
| 29 | Ankle clonus (HP:0011448) | 3.03526641 |
| 30 | Scanning speech (HP:0002168) | 2.99079868 |
| 31 | Nephrogenic diabetes insipidus (HP:0009806) | 2.96815859 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.94647768 |
| 33 | Drooling (HP:0002307) | 2.91017730 |
| 34 | Excessive salivation (HP:0003781) | 2.91017730 |
| 35 | Impaired social interactions (HP:0000735) | 2.88653102 |
| 36 | Abnormal social behavior (HP:0012433) | 2.88653102 |
| 37 | Nephronophthisis (HP:0000090) | 2.88255558 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83290858 |
| 39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.82528184 |
| 40 | Absent/shortened dynein arms (HP:0200106) | 2.82528184 |
| 41 | Genital tract atresia (HP:0001827) | 2.77536546 |
| 42 | Progressive inability to walk (HP:0002505) | 2.76023184 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.74733890 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.74456157 |
| 45 | Anxiety (HP:0000739) | 2.73039614 |
| 46 | Vaginal atresia (HP:0000148) | 2.71142990 |
| 47 | Depression (HP:0000716) | 2.67754815 |
| 48 | Abnormality of the corticospinal tract (HP:0002492) | 2.66883514 |
| 49 | Spastic gait (HP:0002064) | 2.65904396 |
| 50 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.65670719 |
| 51 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.65670719 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.64909379 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.60010754 |
| 54 | Lissencephaly (HP:0001339) | 2.59184624 |
| 55 | Absent speech (HP:0001344) | 2.58311277 |
| 56 | Abnormal ciliary motility (HP:0012262) | 2.58079782 |
| 57 | Urinary urgency (HP:0000012) | 2.54696746 |
| 58 | Genetic anticipation (HP:0003743) | 2.54631860 |
| 59 | Termporal pattern (HP:0011008) | 2.53279136 |
| 60 | Insidious onset (HP:0003587) | 2.53279136 |
| 61 | Postural instability (HP:0002172) | 2.51399357 |
| 62 | Mutism (HP:0002300) | 2.51123360 |
| 63 | Abnormality of the renal medulla (HP:0100957) | 2.50678800 |
| 64 | Congenital stationary night blindness (HP:0007642) | 2.50078929 |
| 65 | Hemiparesis (HP:0001269) | 2.47779205 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.47068302 |
| 67 | Inability to walk (HP:0002540) | 2.46213474 |
| 68 | Diplopia (HP:0000651) | 2.44385113 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.44385113 |
| 70 | Polyphagia (HP:0002591) | 2.40913689 |
| 71 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.38267332 |
| 72 | Impaired smooth pursuit (HP:0007772) | 2.34510133 |
| 73 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.34339301 |
| 74 | Protruding tongue (HP:0010808) | 2.31458040 |
| 75 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.31081327 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.31070222 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 2.30048799 |
| 78 | Stereotypic behavior (HP:0000733) | 2.27101022 |
| 79 | Blue irides (HP:0000635) | 2.27078753 |
| 80 | Pachygyria (HP:0001302) | 2.26452562 |
| 81 | Abnormality of the labia minora (HP:0012880) | 2.26334403 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.24285464 |
| 83 | Cystic liver disease (HP:0006706) | 2.23070565 |
| 84 | Chronic hepatic failure (HP:0100626) | 2.21023869 |
| 85 | Torticollis (HP:0000473) | 2.20926693 |
| 86 | Bradykinesia (HP:0002067) | 2.20142371 |
| 87 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.19615411 |
| 88 | Generalized myoclonic seizures (HP:0002123) | 2.19363360 |
| 89 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17041188 |
| 90 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17041188 |
| 91 | Lower limb muscle weakness (HP:0007340) | 2.16769138 |
| 92 | Status epilepticus (HP:0002133) | 2.16438098 |
| 93 | Poor coordination (HP:0002370) | 2.15744415 |
| 94 | Postaxial hand polydactyly (HP:0001162) | 2.13806903 |
| 95 | Intention tremor (HP:0002080) | 2.12294812 |
| 96 | Gait imbalance (HP:0002141) | 2.10419561 |
| 97 | Akinesia (HP:0002304) | 2.08622881 |
| 98 | Pheochromocytoma (HP:0002666) | 2.08006451 |
| 99 | Dysmetric saccades (HP:0000641) | 2.06625990 |
| 100 | Renal cortical cysts (HP:0000803) | 2.06559849 |
| 101 | Decreased central vision (HP:0007663) | 2.05880027 |
| 102 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.05729704 |
| 103 | Attenuation of retinal blood vessels (HP:0007843) | 2.05692773 |
| 104 | Abnormality of macular pigmentation (HP:0008002) | 2.04107507 |
| 105 | Impaired vibratory sensation (HP:0002495) | 2.02913661 |
| 106 | Increased circulating renin level (HP:0000848) | 2.02909184 |
| 107 | Short tibia (HP:0005736) | 2.02539568 |
| 108 | Spastic tetraplegia (HP:0002510) | 2.02344264 |
| 109 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.01244069 |
| 110 | Focal dystonia (HP:0004373) | 2.00873444 |
| 111 | Optic nerve hypoplasia (HP:0000609) | 1.98909107 |
| 112 | Abnormality of salivation (HP:0100755) | 1.98841603 |
| 113 | Cerebellar dysplasia (HP:0007033) | 1.95795157 |
| 114 | Postaxial foot polydactyly (HP:0001830) | 1.95673119 |
| 115 | Abolished electroretinogram (ERG) (HP:0000550) | 1.94525295 |
| 116 | Incomplete penetrance (HP:0003829) | 1.94507969 |
| 117 | Limb dystonia (HP:0002451) | 1.93506144 |
| 118 | Papilledema (HP:0001085) | 1.92439358 |
| 119 | Psychosis (HP:0000709) | 1.92391981 |
| 120 | Hypoplasia of the brainstem (HP:0002365) | 1.91258403 |
| 121 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.91258403 |
| 122 | Retinal dysplasia (HP:0007973) | 1.91060858 |
| 123 | Acute necrotizing encephalopathy (HP:0006965) | 1.90975344 |
| 124 | Sclerocornea (HP:0000647) | 1.89095733 |
| 125 | Rhinitis (HP:0012384) | 1.89088068 |
| 126 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.89025966 |
| 127 | Neuroendocrine neoplasm (HP:0100634) | 1.87581697 |
| 128 | Hemiplegia (HP:0002301) | 1.86854550 |
| 129 | Specific learning disability (HP:0001328) | 1.85661620 |
| 130 | Thickened helices (HP:0000391) | 1.85081056 |
| 131 | Tubulointerstitial nephritis (HP:0001970) | 1.84975613 |
| 132 | Craniofacial dystonia (HP:0012179) | 1.84837259 |
| 133 | Lower limb amyotrophy (HP:0007210) | 1.84713218 |
| 134 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84596816 |
| 135 | Sensory axonal neuropathy (HP:0003390) | 1.83285982 |
| 136 | Increased corneal curvature (HP:0100692) | 1.83112625 |
| 137 | Keratoconus (HP:0000563) | 1.83112625 |
| 138 | Gait ataxia (HP:0002066) | 1.81043652 |
| 139 | Pendular nystagmus (HP:0012043) | 1.80865625 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.79647553 |
| 141 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77594032 |
| 142 | Abnormal drinking behavior (HP:0030082) | 1.76755883 |
| 143 | Polydipsia (HP:0001959) | 1.76755883 |
| 144 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75785941 |
| 145 | Dyskinesia (HP:0100660) | 1.75516603 |
| 146 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.74121455 |
| 147 | Broad foot (HP:0001769) | 1.74067895 |
| 148 | Abnormality of saccadic eye movements (HP:0000570) | 1.73758911 |
| 149 | Abnormal hair whorl (HP:0010721) | 1.73627745 |
| 150 | Agitation (HP:0000713) | 1.73485226 |
| 151 | Delusions (HP:0000746) | 1.73194834 |
| 152 | Acute encephalopathy (HP:0006846) | 1.73189269 |
| 153 | Peripheral hypomyelination (HP:0007182) | 1.73037676 |
| 154 | Colon cancer (HP:0003003) | 1.72641491 |
| 155 | Occipital encephalocele (HP:0002085) | 1.72122758 |
| 156 | Progressive macrocephaly (HP:0004481) | 1.71598264 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.71478591 |
| 158 | Exotropia (HP:0000577) | 1.69637098 |
| 159 | Congenital primary aphakia (HP:0007707) | 1.67957324 |
| 160 | Type II lissencephaly (HP:0007260) | 1.66632101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.15402940 |
| 2 | NTRK3 | 5.06150004 |
| 3 | CASK | 3.74215300 |
| 4 | FRK | 3.59078283 |
| 5 | MAP3K9 | 3.21847742 |
| 6 | MARK1 | 2.84798983 |
| 7 | MAP3K4 | 2.70763270 |
| 8 | MAP4K2 | 2.62734775 |
| 9 | MAP2K7 | 2.51342683 |
| 10 | DAPK2 | 2.39255598 |
| 11 | MINK1 | 2.29475124 |
| 12 | TNIK | 2.28012006 |
| 13 | MAP3K12 | 2.01683136 |
| 14 | RIPK4 | 2.01089188 |
| 15 | NTRK2 | 1.99054160 |
| 16 | PINK1 | 1.94280881 |
| 17 | NTRK1 | 1.84414809 |
| 18 | TRIM28 | 1.81286580 |
| 19 | BMPR1B | 1.80306444 |
| 20 | KSR2 | 1.73528479 |
| 21 | PLK2 | 1.71525730 |
| 22 | MAP2K4 | 1.70180928 |
| 23 | PRPF4B | 1.69966604 |
| 24 | PAK6 | 1.69705329 |
| 25 | DAPK1 | 1.63035534 |
| 26 | CDK19 | 1.61865914 |
| 27 | MAPK13 | 1.58396488 |
| 28 | PNCK | 1.56949809 |
| 29 | DYRK2 | 1.53750005 |
| 30 | KSR1 | 1.51521792 |
| 31 | GRK1 | 1.51362646 |
| 32 | CSNK1G3 | 1.50837724 |
| 33 | CSNK1A1L | 1.44843440 |
| 34 | CDK5 | 1.43226771 |
| 35 | CSNK1G1 | 1.39292906 |
| 36 | ZAK | 1.35161981 |
| 37 | OXSR1 | 1.32620274 |
| 38 | EPHA3 | 1.31294802 |
| 39 | ARAF | 1.27977287 |
| 40 | INSRR | 1.27062073 |
| 41 | PRKCG | 1.24866414 |
| 42 | GRK5 | 1.23972813 |
| 43 | FES | 1.23099549 |
| 44 | CAMKK1 | 1.22759799 |
| 45 | CAMK2A | 1.19600694 |
| 46 | CAMK2B | 1.16401456 |
| 47 | CAMKK2 | 1.11829697 |
| 48 | NUAK1 | 1.09712400 |
| 49 | SIK2 | 1.09628735 |
| 50 | MAP3K2 | 0.99881872 |
| 51 | CSNK1G2 | 0.99121089 |
| 52 | UHMK1 | 0.96245087 |
| 53 | TAOK3 | 0.95644072 |
| 54 | SGK494 | 0.95133086 |
| 55 | SGK223 | 0.95133086 |
| 56 | MAP3K13 | 0.89188647 |
| 57 | MARK2 | 0.88844010 |
| 58 | ERBB3 | 0.88708694 |
| 59 | PRKD3 | 0.87068162 |
| 60 | STK39 | 0.86018992 |
| 61 | CDK18 | 0.85408120 |
| 62 | STK38L | 0.85239422 |
| 63 | CDK14 | 0.83401563 |
| 64 | PHKG1 | 0.82235987 |
| 65 | PHKG2 | 0.82235987 |
| 66 | CDK15 | 0.82226672 |
| 67 | AKT3 | 0.82064047 |
| 68 | PTK2B | 0.81039592 |
| 69 | BMPR2 | 0.79950659 |
| 70 | STK38 | 0.79563135 |
| 71 | STK11 | 0.76084024 |
| 72 | PRKCE | 0.75828763 |
| 73 | CAMK1 | 0.74098608 |
| 74 | NME1 | 0.73919544 |
| 75 | TYRO3 | 0.73616711 |
| 76 | CCNB1 | 0.73273357 |
| 77 | SGK1 | 0.72644370 |
| 78 | RAF1 | 0.71860366 |
| 79 | SGK2 | 0.71361230 |
| 80 | CDK11A | 0.70744545 |
| 81 | CAMK2D | 0.69152696 |
| 82 | CAMK4 | 0.66710085 |
| 83 | BCR | 0.65867317 |
| 84 | FGR | 0.65208808 |
| 85 | GRK7 | 0.65184200 |
| 86 | TIE1 | 0.63449485 |
| 87 | RPS6KA4 | 0.61665031 |
| 88 | PAK3 | 0.60943717 |
| 89 | ACVR1B | 0.59008685 |
| 90 | DYRK1A | 0.58613537 |
| 91 | CAMK2G | 0.57429518 |
| 92 | LATS2 | 0.57144396 |
| 93 | SIK3 | 0.55589746 |
| 94 | TXK | 0.55454508 |
| 95 | MKNK2 | 0.55033818 |
| 96 | PRKCH | 0.53632286 |
| 97 | VRK1 | 0.52786762 |
| 98 | TNK2 | 0.52338415 |
| 99 | MAPK15 | 0.52122757 |
| 100 | DYRK3 | 0.51064996 |
| 101 | PDPK1 | 0.50765918 |
| 102 | BRAF | 0.50497691 |
| 103 | NEK6 | 0.49803895 |
| 104 | PKN1 | 0.47973980 |
| 105 | RET | 0.47953055 |
| 106 | CSNK1A1 | 0.47919792 |
| 107 | FER | 0.47580450 |
| 108 | TAOK1 | 0.47477779 |
| 109 | PRKG1 | 0.47147263 |
| 110 | WNK1 | 0.46377874 |
| 111 | FYN | 0.46132723 |
| 112 | PDK1 | 0.44976768 |
| 113 | CSNK1D | 0.44824049 |
| 114 | BCKDK | 0.43802116 |
| 115 | RPS6KA3 | 0.43336691 |
| 116 | ADRBK1 | 0.43147040 |
| 117 | PRKCZ | 0.42939429 |
| 118 | SGK3 | 0.42397981 |
| 119 | SRPK1 | 0.41364993 |
| 120 | MAP2K1 | 0.40246269 |
| 121 | DAPK3 | 0.39710956 |
| 122 | ROCK2 | 0.39512324 |
| 123 | LIMK1 | 0.38850763 |
| 124 | WNK3 | 0.38768671 |
| 125 | MAPK12 | 0.38502346 |
| 126 | ADRBK2 | 0.38344048 |
| 127 | * PRKCA | 0.37940247 |
| 128 | CDC42BPA | 0.37019883 |
| 129 | TGFBR1 | 0.36436519 |
| 130 | MAP3K6 | 0.36040321 |
| 131 | CDK3 | 0.36027306 |
| 132 | MAP3K1 | 0.35953493 |
| 133 | WNK4 | 0.35144223 |
| 134 | RPS6KA5 | 0.34843030 |
| 135 | PRKACA | 0.34071427 |
| 136 | LMTK2 | 0.33953976 |
| 137 | CSNK1E | 0.32405903 |
| 138 | PRKCB | 0.31913778 |
| 139 | CAMK1G | 0.31370067 |
| 140 | PLK3 | 0.31113948 |
| 141 | PRKACB | 0.30725237 |
| 142 | FGFR2 | 0.27441421 |
| 143 | TLK1 | 0.27243512 |
| 144 | PRKCQ | 0.26143877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.34812775 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30832359 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.96874130 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79371413 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.79270471 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.78528213 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.71047808 |
| 8 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.69162983 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64954492 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.55127055 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.19010223 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16740972 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.06943240 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.98073128 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.97868552 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94371488 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91880430 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91386395 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90858338 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.90337417 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88616845 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.83479978 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.79828609 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72188818 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71587469 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71411860 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68396629 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.67402593 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63353403 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53196076 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52636884 |
| 32 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39736094 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38308950 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36870175 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34941268 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.33768509 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33634682 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33393354 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.30290987 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29410345 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28892991 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25543002 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.24004289 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18110123 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16817776 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14654300 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09584828 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07281804 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 1.06988746 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03941602 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03690895 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02578869 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99464505 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.99348362 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98909580 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.96270137 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.93914914 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93704736 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90219393 |
| 60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88874413 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87728363 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86558396 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86249372 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85942022 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83805222 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81858219 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.81061152 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79110230 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77264777 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77159785 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76756818 |
| 72 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75307040 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.75040322 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72490045 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70649505 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70595064 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69827036 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68759236 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68374481 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67660200 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67060578 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66923165 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.65329913 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65226842 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64965564 |
| 86 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64249773 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.62360037 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62328124 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61747501 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61382141 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58276252 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57469696 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.57305236 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54657878 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54195917 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54163936 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53830713 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53351084 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52049502 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50259742 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49801133 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48977211 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.48492291 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48154431 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47684831 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45177560 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45064595 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44103219 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43717239 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43652463 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42601814 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42356900 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42321781 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42227581 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41514881 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40885261 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40265285 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39820606 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39175639 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.39046803 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37923405 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37517838 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37474383 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37295556 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36944451 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35854649 |
| 127 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35098412 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.34874657 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34234708 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33926299 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33330919 |
| 132 | Purine metabolism_Homo sapiens_hsa00230 | 0.33086162 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31175014 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.31114558 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30756334 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30235409 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26262685 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23554223 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23076627 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22777155 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.22120820 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21528942 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19720416 |

